As of today (2024-04-16), Sartorius AG's share price is €342.40.
Sartorius AG's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €4.32. Hence, Sartorius AG's Price-to-Free-Cash-Flow Ratio for today is 79.30.
The historical rank and industry rank for Sartorius AG's Price-to-Free-Cash-Flow or its related term are showing as below:
XTER:SRT3'
s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 31.89 Med: 84.88 Max: 820.36
Current: 59.75
During the past 13 years, Sartorius AG's highest Price-to-Free-Cash-Flow Ratio was 820.36. The lowest was 31.89. And the median was 84.88.
XTER:SRT3's Price-to-Free-Cash-Flow is ranked worse than 74.63% of 335
companies
in the Medical Devices & Instruments industry
Industry Median: 30.85
vs XTER:SRT3: 59.75
During the past 12 months, the average Free Cash Flow per Share Growth Rate of Sartorius AG was 38.90% per year.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was 29.40% per year.
During the past 5 years, the average Free Cash Flow per Share Growth Rate was 98.80% per year.
During the past 10 years, the average Free Cash Flow per Share Growth Rate was 46.60% per year.
During the past 13 years, Sartorius AG's highest 3-Year average Free Cash Flow per Share Growth Rate was 334.50% per year. The lowest was -40.00% per year. And the median was 14.70% per year.
Sartorius AG Price-to-Free-Cash-Flow Historical Data
The historical data trend for Sartorius AG's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Sartorius AG Annual Data
Trend
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Dec22
Dec23
Price-to-Free-Cash-Flow
78.94
87.06
36.65
54.11
30.86
Sartorius AG Quarterly Data
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Sep23
Dec23
Price-to-Free-Cash-Flow
54.11
119.41
86.52
83.20
30.86
Competitive Comparison
For the Medical Instruments & Supplies subindustry, Sartorius AG's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sartorius AG Price-to-Free-Cash-Flow Distribution
For the Medical Devices & Instruments industry and Healthcare sector, Sartorius AG's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Sartorius AG's Price-to-Free-Cash-Flow falls into.
Sartorius AG Price-to-Free-Cash-Flow Calculation
Sartorius AG's Price-to-Free-Cash-Flow ratio for today is calculated as
Sartorius AG's Share Price of today is €342.40.
Sartorius AG's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €4.32.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Sartorius AG (XTER:SRT3) Price-to-Free-Cash-Flow Explanation
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
Sartorius AG Price-to-Free-Cash-Flow Related Terms
Thank you for viewing the detailed overview of Sartorius AG's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
Sartorius AG is a leading provider of bioprocessing solutions. Its Bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs, and has a focus on single-use technology, or SUT. Its Lab Products and Services division offers a wide range of products for lab use, including scales, pipettes, and filtration equipment. As of 2022, the Bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 74% ownership and 85% voting control. The business is geographically diverse, with revenue across Europe, the Middle East, and Africa (37% of 2022 sales), the Americas (37%), and Asia-Pacific (26%). We estimate China revenue to be around 10%.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XTER:SRT3 has been successfully added to your 